Mesa Biotech

2 articles about Mesa Biotech

• Mesa Biotech Named 2019 Frost & Sullivan Price/Performance Value Leader in Global Influenza Point-of-Care Testing

  3/20/2019

  Mesa Biotech Inc., is a privately held, molecular diagnostic company that developed an affordable and easy to operate polymerase chain reaction testing platform designed specifically for point-of-care infectious disease diagnosis.

• Mesa Biotech Obtains CE Mark for its Accula RSV Molecular Point of Care Test

  11/13/2018

   Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC), today announced it has obtained CE Mark in the European Union (EU) for its Accula™ RSV Test.